Direct Oral Anticoagulants (DOAC’s) Market Expands Rapidly with Rising Cardiovascular Disease Burden and Advanced Therapeutics

https://growthmarketreports.co....m/report/direct-oral

The global Direct Oral Anticoagulants (DOAC’s) Market
is experiencing substantial growth, driven by the increasing prevalence of cardiovascular diseases and thromboembolic disorders. These medications are widely preferred for their effectiveness, convenience, and reduced need for routine monitoring compared to traditional anticoagulants.